Structures by: Dawson A.
Total: 41
2
C26H50O2
Organic letters (2005) 7, 14 2841-2843
a=19.4695(10)Å b=19.4695(10)Å c=26.580(2)Å
α=90.00° β=90.00° γ=90.00°
1
C28H54
Organic letters (2005) 7, 14 2841-2843
a=10.639(3)Å b=27.103(8)Å c=10.096(3)Å
α=90.00° β=116.417(5)° γ=90.00°
Paracetamol monomethanolate
C9H13N1O3
Chemical Communications (Cambridge, United Kingdom) (2003) 24 3004-3005
a=7.630(2)Å b=17.209(3)Å c=7.3710(11)Å
α=90° β=115.52(3)° γ=90°
Sulfuric acid
H2SO4
Journal of the Chemical Society, Dalton Transactions (2002) 8 1867
a=7.695(13)Å b=4.559(7)Å c=8.378(3)Å
α=90° β=107.42(8)° γ=90°
[Pt1N2O4C19H12].[NC4H36]2.C2O1H6.C4O2H8
[Pt1N2O4C19H12].[NC4H36]2.C2O1H6.C4O2H8
Dalton Transactions (2003) 19 3757
a=16.4091(7)Å b=14.4709(6)Å c=27.5157(12)Å
α=90.00° β=105.5480(10)° γ=90.00°
(C10H6N4O4).(C4H8O2)
(C10H6N4O4).(C4H8O2)
Dalton transactions (Cambridge, England : 2003) (2012) 41, 1 201-207
a=6.4941(6)Å b=6.5761(6)Å c=9.3664(8)Å
α=85.2000(10)° β=87.9100(10)° γ=66.0050(10)°
C10H7N3O2
C10H7N3O2
Dalton transactions (Cambridge, England : 2003) (2012) 41, 1 201-207
a=7.4647(3)Å b=10.1931(4)Å c=11.7396(4)Å
α=90.00° β=90.00° γ=90.00°
C23H19Cl4N9O9Pt2
C23H19Cl4N9O9Pt2
Dalton transactions (Cambridge, England : 2003) (2012) 41, 1 201-207
a=14.3359(12)Å b=14.1844(12)Å c=14.9479(13)Å
α=90.00° β=99.909(2)° γ=90.00°
Paracetamol monomethanolate
C9H13N1O3
Chemical Communications (Cambridge, United Kingdom) (2003) 24 3004-3005
a=7.630(2)Å b=17.209(3)Å c=7.3710(11)Å
α=90° β=115.52(3)° γ=90°
L-alanine-d8
C3D7NO2
CrystEngComm (2010) 12, 9 2573
a=6.0186(6)Å b=12.3298(11)Å c=5.7828(4)Å
α=90° β=90° γ=90°
L-alanine-d8
C3D7NO2
CrystEngComm (2010) 12, 9 2573
a=5.9004(10)Å b=12.298(2)Å c=5.7626(8)Å
α=90° β=90° γ=90°
C3D7NO2
C3D7NO2
CrystEngComm (2010) 12, 9 2573
a=5.8204(9)Å b=12.2496(18)Å c=5.7419(8)Å
α=90° β=90° γ=90°
C3D7NO2
C3D7NO2
CrystEngComm (2010) 12, 9 2573
a=5.7830(5)Å b=12.2194(9)Å c=5.7287(4)Å
α=90° β=90° γ=90°
L-alanine-d8
C3D7NO2
CrystEngComm (2010) 12, 9 2573
a=5.7345(4)Å b=12.1746(7)Å c=5.7095(3)Å
α=90° β=90° γ=90°
C3D7NO2
C3D7NO2
CrystEngComm (2010) 12, 9 2573
a=5.5556(3)Å b=11.9110(7)Å c=5.6233(3)Å
α=90° β=90° γ=90°
C3D7NO2
C3D7NO2
CrystEngComm (2010) 12, 9 2573
a=5.4850(5)Å b=11.7729(10)Å c=5.5875(5)Å
α=90° β=90° γ=90°
C3D7NO2
C3D7NO2
CrystEngComm (2010) 12, 9 2573
a=5.4221(3)Å b=11.6457(6)Å c=5.5564(3)Å
α=90° β=90° γ=90°
C3D7NO2
C3D7NO2
CrystEngComm (2010) 12, 9 2573
a=5.2815(5)Å b=11.3765(10)Å c=5.4879(5)Å
α=90° β=90° γ=90°
C3D7NO2
C3D7NO2
CrystEngComm (2010) 12, 9 2573
a=5.2626(3)Å b=11.3404(6)Å c=5.4786(3)Å
α=90° β=90° γ=90°
C3D7NO2
C3D7NO2
CrystEngComm (2010) 12, 9 2573
a=5.2459(4)Å b=11.3088(8)Å c=5.4696(4)Å
α=90° β=90° γ=90°
H2 (S O4)
H2O4S
Journal of the Chemical Society. Dalton Transactions (2002) 2002, 1867-1871
a=7.905Å b=4.591Å c=8.749Å
α=90° β=108.17° γ=90°
H2 (S O4)
H2O4S
Journal of the Chemical Society. Dalton Transactions (2002) 2002, 1867-1871
a=8.087Å b=5.007Å c=8.899Å
α=90° β=110.47° γ=90°
PhOH
PhOH
Acta Crystallographica Section B (2002) 58, 6 1018-1024
a=11.610(4)Å b=5.4416(11)Å c=12.217(5)Å
α=90.00° β=101.47(3)° γ=90.00°
Acetic acid
C2H4O2
Journal of Applied Crystallography (2004) 37, 3 410-416
a=3.9447(6)Å b=13.028(2)Å c=5.6407(9)Å
α=90° β=93.177(12)° γ=90°
ALPOP
[Al(C14H9N2O2)3]0.167H2O1
Acta Crystallographica Section E (2004) 60, 11 m1644-m1646
a=15.3472(11)Å b=19.6520(14)Å c=36.444(3)Å
α=90.00° β=91.8281(17)° γ=90.00°
Cl4Ti
Cl4Ti
Acta Crystallographica, Section E (2002) 58, i95-i97
a=9.670(2)Å b=6.4737(15)Å c=9.682(2)Å
α=90° β=102.168(4)° γ=90°
4''-cyano-7,7''-dimethoxy-3',6'-dioxodispiro[indane-2,2'-piperazine- 5',2''-indane]-4-carboxamide methanol solvate
C24H22N4O5,CH4O
Acta Crystallographica Section C (2008) 64, 8 o431-o433
a=9.6409(7)Å b=10.4629(8)Å c=25.5588(19)Å
α=90.00° β=90.00° γ=90.00°
C15H22BClN6S3Zn,CH2Cl2
C15H22BClN6S3Zn,CH2Cl2
Inorganic Chemistry (2005) 44, 8884-8898
a=9.0230(18)Å b=10.277(2)Å c=14.641(3)Å
α=90.361(3)° β=91.097(3)° γ=111.863(2)°
C25H36BN6RuS3,H2O,Cl
C25H36BN6RuS3,H2O,Cl
Inorganic Chemistry (2005) 44, 8884-8898
a=10.2524(14)Å b=12.0839(16)Å c=24.863(3)Å
α=90.00° β=91.353(2)° γ=90.00°
C15H22BBrCdN6S3,C4H8O
C15H22BBrCdN6S3,C4H8O
Inorganic Chemistry (2005) 44, 8884-8898
a=9.6512(3)Å b=9.8621(3)Å c=14.5689(5)Å
α=105.337(2)° β=92.140(2)° γ=93.245(2)°
C33H37B1Cu1N6P1S3
C33H37B1Cu1N6P1S3
Inorganic Chemistry (2005) 44, 8884-8898
a=15.5870(16)Å b=15.5870(16)Å c=12.144(2)Å
α=90° β=90° γ=120°
Alpha glycine
C2H5N1O2
Crystal Growth & Design (2005) 5, 4 1415
a=4.9669(9)Å b=11.459(4)Å c=5.4231(12)Å
α=90° β=114.916(15)° γ=90°
Alpha glycine
C2H5N1O2
Crystal Growth & Design (2005) 5, 4 1415
a=4.8690(7)Å b=11.139(3)Å c=5.3777(10)Å
α=90° β=116.888(11)° γ=90°
Gamma glycine
C2H5N1O2
Crystal Growth & Design (2005) 5, 4 1415
a=6.9332(6)Å b=6.9332(6)Å c=5.4552(8)Å
α=90° β=90° γ=120°
Gamma Glycine
C2H5N1O2
Crystal Growth & Design (2005) 5, 4 1415
a=6.8617(4)Å b=6.8617(4)Å c=5.4282(6)Å
α=90° β=90° γ=120°
Delta glycine
C2H5N1O2
Crystal Growth & Design (2005) 5, 4 1415
a=11.156(4)Å b=5.8644(11)Å c=5.3417(17)Å
α=90° β=125.83(4)° γ=90°
Epsilon glycine
C2H5N1O2
Crystal Growth & Design (2005) 5, 4 1415
a=4.8887(10)Å b=5.7541(11)Å c=5.4419(11)Å
α=90° β=116.682(10)° γ=90°
C12H12S2V
C12H12S2V
Inorganic Chemistry (2007) 46, 25 10639-10646
a=11.3051(10)Å b=7.5236(7)Å c=13.3767(12)Å
α=90.00° β=104.849(2)° γ=90.00°
C3D7NO2
C3D7NO2
CrystEngComm (2010) 12, 9 2573
a=5.3626(4)Å b=11.5291(9)Å c=5.5263(4)Å
α=90° β=90° γ=90°
C3D7NO2
C3D7NO2
CrystEngComm (2010) 12, 9 2573
a=5.3105(3)Å b=11.4299(6)Å c=5.5015(3)Å
α=90° β=90° γ=90°
Cl4Ti
Cl4Ti
Acta Crystallographica, Section E (2002) 58, i95-i97
a=9.670Å b=6.4737Å c=9.682Å
α=90° β=102.168° γ=90°